Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
Crossref DOI link: https://doi.org/10.1186/s13046-019-1518-z
Published Online: 2020-01-13
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lai, Ssu-Chuan
Su, Yu-Ting
Chi, Ching-Chi
Kuo, Yung-Che
Lee, Kam-Fai
Wu, Yu-Chih
Lan, Pei-Chi
Yang, Muh-Hwa
Chang, Te-Sheng
Huang, Yen-Hua
Text and Data Mining valid from 2020-01-13
Version of Record valid from 2020-01-13
Article History
First Online: 13 January 2020